AVITA Medical, Inc.

RCEL · NasdaqCM

Price$0.00+0.00 (+0.00%)

Price History

Volume & Moving Averages

Price50D200D

Analyst Price Target

$0.00▲ 0.0% above current price

Range: $0.00 – $0.00 · 0 analysts

Based on Wall Street analyst estimates — not a Stockinder prediction.

About the company

Jarvis is thinking

Key Metrics

Report card

Open as standalone page ↗

Jarvis is thinking

Recent Notable Coverage

Jarvis is thinking

Report Card

Growth

Health

Risk

–

Value

Quality

Ownership

Insider and institutional holdings, from Yahoo Finance — for Indian companies this roughly tracks promoter (insiders) and combined FII/DII (institutions) stakes, though not split out the same way a shareholding-pattern filing would.

Insiders1.5%

Institutions16.0%

Public / Other

Income Statement

	2025-12-31	2024-12-31	2022-12-31	2021-06-30	2020-06-30
Total money the company brought in from its core business during the period, before any costs are subtracted.	$70.88M	$63.89M	$34.42M	$29.23M	$14.26M
The direct costs of producing what was sold — raw materials, manufacturing, direct labor.	$12.79M	$9.09M	$6.04M	$5.95M	$2.97M
Revenue left after subtracting the direct cost of producing goods or services — how efficiently the core business converts sales into profit before overhead.	$58.82M	$55.16M	$28.38M	$23.28M	$11.29M
Gross profit as a percentage of revenue.	83.0%	86.3%	82.4%	79.6%	79.2%
Profit from core operations after subtracting the cost of revenue and operating expenses like R&D and marketing, but before interest and taxes.	-$42.53M	-$56.59M	-$27.50M	-$26.54M	-$42.68M
Operating income as a percentage of revenue.	-60.0%	-88.6%	-79.9%	-90.8%	-299.2%
The company's bottom-line profit after all expenses, interest, and taxes are subtracted.	-$48.59M	-$61.84M	-$26.66M	-$26.58M	-$42.03M
Net income divided by the number of shares outstanding — profit attributable to each share.	$-1.74	$-2.39	$1.07	$1.17	$2.07
Like basic EPS, but accounts for shares that could be created from stock options or convertible securities — a more conservative per-share profit figure.	$-1.74	$-2.39	$1.07	$1.17	$2.07

Balance Sheet

	2025-12-31	2024-12-31	2022-12-31	2021-06-30	2020-06-30
Cash and highly liquid short-term investments the company can access almost immediately.	$10.24M	$14.05M	$18.16M	$110.75M	$73.64M
Everything the company owns that has value — cash, property, inventory, investments, and more.	$56.39M	$79.71M	$98.26M	$125.50M	$82.46M
All of the company's interest-bearing borrowings, short and long term combined.	$42.98M	$42.24M	–	–	–
Everything the company owes — debt, unpaid bills, and other obligations.	$73.04M	$74.97M	$12.97M	$9.85M	$10.06M
What would be left for shareholders if the company sold all its assets and paid off all its debts — total assets minus total liabilities.	-$16.65M	$4.50M	$84.74M	$115.66M	$72.40M

Cash Flow Statement

	2025-12-31	2024-12-31	2022-12-31	2021-06-30	2020-06-30
Actual cash generated by the core business, as opposed to accounting profit, which can include non-cash items.	-$31.20M	-$48.94M	-$19.09M	-$25.90M	-$22.75M
Cash spent on physical assets like property, equipment, and infrastructure to maintain or grow the business.	$1.00M	$9.17M	$452000	$894000	$590000
Cash left over after capital expenditures — money the company could use for dividends, buybacks, debt repayment, or reinvestment.	-$32.20M	-$58.11M	-$19.54M	-$26.80M	-$23.34M

	You	Peer avg
P/E	–	3.8
Revenue Growth	+17.8%	-61.0%
ROE	–	-31.9%

AVITA Medical, Inc.

Price History

Volume & Moving Averages

Analyst Price Target

About the company

Key Metrics

Report card

Jarvis Analysis

Recent Notable Coverage

Report Card

Ownership

Quick Actions

Income Statement

Balance Sheet

Cash Flow Statement

Reports & Coverage

Con Call Reports

Board of Directors / Annual Reports

Recent Articles

Peer Comparison